New pill shows promise for Hard-to-Treat cancers in early trial
NCT ID NCT06846099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called RP903 in 69 people with advanced solid tumors (like ovarian, breast, or cervical cancer) who had run out of standard options. The main goals were to check safety, find the best dose, and see if the drug shrinks tumors. It is an early-phase trial, so results will guide future studies rather than offer a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Cancer Hospital of Fudan University
Shanghai, China
-
Affiliated Hospital of Jining Medical College
Jining, China
-
Beijing Cancer Hospital
Beijing, China
-
Ceneral Hosipital of Ningxia Medical University
Yinchuan, China
-
Chongqing University Cancer Hospital
Chongqing, China
-
Fujian Cancer Hospital
Fuzhou, China
-
Fujian Medical University Union Hospital
Fuzhou, China
-
Guangxi Medical University Cancer Hospital
Nanning, China
-
Harbin Medical University Cancer Hospital
Harbin, China
-
Henan Cancer Hospital
Zhengzhou, China
-
Hubei Cancer Hospital
Wuhan, China
-
Jilin Cancer Hospital
Changchun, China
-
Jilin University First Hospital
Changchun, China
-
Liaoning Cancer Hospital&Institute
Shenyang, China
-
Linyi Cancer Hospital
Linyi, China
-
Shandong Cancer Hospital & Institute
Jinan, China
-
Sichuan Cancer Hospital
Chengdu, China
-
Sir Run Run Shaw Hospital
Hangzhou, China
-
Suining Central Hospital
Suining, China
-
The Affiliated Hospital of Qingdao University
Qingdao, China
-
The First Affiliated Hospital of Bengbu Medical College
Bengbu, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, China
-
Zhejiang Cancer Hospital
Hangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a new drug combo revive Immunotherapy's power against resistant tumors?